- home
- about us
- Investment Approach
- Client Service Approach
- Market Analysis Summary
- Mission Statement
- Value Proposition
- Team Biographies
- Firm ADV PDFs
- Form CRS
- Firm Brochure-Part 2A of Form ADV
- Brochure Supplement Amit Stavinsky
- Brochure Supplement Frank Parks
- Brochure Supplement Dominick Savo
- Brochure Supplement Richard Mason
- Brochure Supplement Joe Estes
- Brochure Supplement Jonathan Ezra
- Statement Of Financial Strength
- Job Opportunities
- Letter to Clients
- member log-in
- contact us
Latest News about CRSP
Recent news which mentions CRSP
Where Will CRISPR Therapeutics Be in 1 Year?
July 31, 2022
From Motley Fool
2 Biotech Stocks That Could Help Make You a Fortune
July 30, 2022
From Motley Fool
Will a Recession Cause a Housing Crash in 2022?
July 27, 2022
From InvestorPlace
7 Undervalued Biotech Stocks to Buy Before They Boom
July 25, 2022
From InvestorPlace
2 Biotech Stocks to Help Recession-Proof Your Portfolio
July 22, 2022
From Motley Fool
2 Unstoppable Growth Stocks to Buy and Hold for Decades
July 21, 2022
From Motley Fool
Down 35% This Year, Is This Small-Cap Stock a Buy?
July 21, 2022
From Motley Fool
If You Invested $5,000 in Vertex Pharmaceuticals in 2017, This Is How Much You Would Have Today
July 20, 2022
From Motley Fool
From Motley Fool
6 Cathie Wood Stocks to Buy on the Dip
July 14, 2022
From InvestorPlace
From Motley Fool
From Motley Fool
5 Best Stocks to Buy if You Have $100 to Spend
July 10, 2022
From InvestorPlace
This Company Could Ease the Pain in a Bear Market
July 09, 2022
From Motley Fool
3 No-Brainer Stocks to Buy in July
July 09, 2022
From Motley Fool
The 3 Leaders of the Gene Editing Revolution
July 08, 2022
From InvestorPlace
7 Moonshot Investments Upending a $10 Trillion Industry
July 08, 2022
From InvestorPlace
From Motley Fool
7 Best Biotech Stocks to Buy in July 2022
July 08, 2022
From InvestorPlace
From Motley Fool
Want to Beat the Bear Market? Try These 2 Stocks
July 08, 2022
From Motley Fool
3 Top Healthcare Stocks to Buy for July
July 07, 2022
From Motley Fool
2 Reasons to Buy Vertex Pharmaceuticals Now
July 05, 2022
From Motley Fool
If You Invested $25,000 in Vertex Pharmaceuticals 5 Years Ago, This Is How Much You Would Have Today
July 01, 2022
From Motley Fool
From Motley Fool
Jim Cramer Says This Company Isn't Making Money
June 24, 2022
From Benzinga
Should You Sell Biotech Stocks If There's a Recession?
June 23, 2022
From Motley Fool
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.